The agency approved competing vaccines from Pfizer-BioNTech and Moderna last month.
Novavax stock shot higher after the Food and Drug Administration gave the go-ahead to its updated vaccine for Covid-19, after competing vaccines from Pfizer – BioNTech and Moderna were approved last month.
The Novavax vaccine is authorized for use in people ages 12 and up, a narrower population than the Pfizer and Moderna vaccines, which are authorized for use in people older than 6 months. The Centers for Disease Control and Prevention’s recommendation of the Pfizer and Moderna vaccines last month also covers the Novavax vaccine, so no additional meeting of that agency’s vaccine advisors will be needed.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Novavax Stock Jumps After FDA Approves Updated Covid VaccineShares were up more than 10% on the news, which came more than three weeks after vaccines from Moderna and Pfizer.
Read more »
Novavax updated COVID vaccine gets FDA approvalStock jumps 12% on regulatory approval of new shot
Read more »
Nvidia stock jumps as Goldman adds chipmaker to ‘Conviction buy’ listGoldman, which boosted its price target on Nvidia to $605 per share in August, added the AI market leader to its flagship list of stock recommendations Monday.
Read more »
Sphere Entertainment Stock Jumps 11% Following U2’s Debut Concert at Vegas VenueThe band’s christening of the showstopping $2.3 billion space on Friday (Sept. 29) got investors’ attention.
Read more »
Nevada Copper stock jumps as it resumes ore processing at Pumpkin HollowBy mid-October, the throughput is planned to be increased steadily towards a goal of achieving steady state operations of 4,500-5,000 tpd by the end of 2023.
Read more »
Fantasy Football Stock Up, Stock DownWith a quarter of the NFL season in the books, here’s a look at some of the biggest fantasy winners ... and a few disappointments.
Read more »